AB Science Statistics
Total Valuation
AB Science has a market cap or net worth of 109.20 million. The enterprise value is 120.37 million.
| Market Cap | 109.20M |
| Enterprise Value | 120.37M |
Important Dates
The next estimated earnings date is Wednesday, April 30, 2025.
| Earnings Date | Apr 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +9.19% |
| Shares Change (QoQ) | -0.13% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 21.73M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 94.20 |
| PB Ratio | -4.14 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -18.59 |
| EV / Sales | 97.98 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -25.00 |
Financial Position
The company has a current ratio of 0.82
| Current Ratio | 0.82 |
| Quick Ratio | 0.78 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -4.22 |
| Interest Coverage | -7.04 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -18.16% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -150.18% |
| Revenue Per Employee | 28,983 |
| Profits Per Employee | -161,872 |
| Employee Count | 57 |
| Asset Turnover | 0.04 |
| Inventory Turnover | 0.65 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +156,999,900.00% in the last 52 weeks. The beta is 1.69, so AB Science's price volatility has been higher than the market average.
| Beta (5Y) | 1.69 |
| 52-Week Price Change | +156,999,900.00% |
| 50-Day Moving Average | 10.23 |
| 200-Day Moving Average | 13.28 |
| Relative Strength Index (RSI) | 31.33 |
| Average Volume (20 Days) | 8,458 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, AB Science had revenue of 1.16 million and -6.47 million in losses. Loss per share was -0.13.
| Revenue | 1.16M |
| Gross Profit | 883,960 |
| Operating Income | -8.74M |
| Pretax Income | -6.47M |
| Net Income | -6.47M |
| EBITDA | -9.20M |
| EBIT | -8.74M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 9.78 million in cash and 20.32 million in debt, giving a net cash position of -10.54 million.
| Cash & Cash Equivalents | 9.78M |
| Total Debt | 20.32M |
| Net Cash | -10.54M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -26.36M |
| Book Value Per Share | -0.45 |
| Working Capital | -3.38M |
Cash Flow
In the last 12 months, operating cash flow was -4.55 million and capital expenditures -268,938, giving a free cash flow of -4.81 million.
| Operating Cash Flow | -4.55M |
| Capital Expenditures | -268,938 |
| Free Cash Flow | -4.81M |
| FCF Per Share | n/a |
Margins
| Gross Margin | 76.25% |
| Operating Margin | -754.25% |
| Pretax Margin | -557.76% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AB Science does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.19% |
| Shareholder Yield | -9.19% |
| Earnings Yield | -5.93% |
| FCF Yield | -4.41% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |